相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

追踪药品的监管风险管理承诺提供了更好的透明度和监督

Simon Ingate¹, Kate Bendall², Christopher Long³

¹Axian Consulting Limited, The Bradfield Centre, 184 Cambridge Science Park, Cambridge, CB2 0GA, UK. singate@axian.consulting.

Therapeutic innovation & regulatory science

|June 20, 2025

概括

制药公司必须管理复杂的风险管理计划 (RMP) 和额外的风险最小化材料 (aRMM). 一个新的数据库系统简化了这些关键药物安全文件的跟踪和部署.

科学领域:

药监和药物安全药监和药物安全
监管事务监管事务
医疗信息学医疗信息学

背景情况:

制药公司需要风险管理计划 (RMP) 进行营销许可,详细说明有效性,安全性和许可后药监督 (PV) 承诺.
风险管理计划随着新的数据和适应症而演变,导致多个版本,并且可能需要为医疗保健专业人员和患者提供额外的风险最小化材料 (aRMM).
在全球范围内实施RMP和aRMM涉及复杂的本地化,监管批准,传播和有效性跟踪,这给数据管理带来了重大挑战.

研究的目的:

探索开发和部署一个基于数据库的系统来跟踪风险管理计划 (RMP) 和额外的风险最小化材料 (aRMM).
解决因管理多个版本的RMP和aRMM以及相关的全球活动而产生的关键数据管理问题.
评估实施此类系统对制药组织的影响.

主要方法:

系统地确定基于数据库的RMP和aRMM跟踪系统的要求.
拟议的追踪系统的开发和部署.
评估系统对组织流程和数据管理的影响.

主要成果:

一个基于数据库的系统的开发和实施有效地管理多个RMP和aRMM版本.
改进了对不同市场的文件状态和当地商定的活动的跟踪.
证明对管理全球风险管理承诺的组织效率产生积极影响.

结论:

一个数据库驱动的跟踪系统对于在制药行业有效管理复杂的RMP和aRMM至关重要.
该系统通过简化药物监督活动,增强对药物益处风险概况的理解和控制.
成功实施会提高全球药物安全管理的监管合规性和运营效率.

关键词:

额外的风险最小化措施风险管理承诺风险管理承诺降低风险最小化降低风险最小化追踪追踪追踪追踪

更多相关视频

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

相关概念视频

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Global Regulatory Systems

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...